Nurad Biotech Private Limited
About Nurad Biotech Private Limited
Data last updated:
Nurad Biotech Private Limited is a private limited company based in Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 25 July 2024.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2024PTC434584.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Vandana Kalra and Rajesh Dua.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 14 Block – Tp, Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.15 Lakh. For the same year it recorded a net profit of ₹1.51 Lakh (net margin 10%) and EBITDA of ₹2.11 Lakh (EBITDA margin 13.9%).
Company details
Contact details
Nurad Biotech Private Limited's registered office is in Delhi, Delhi.
- Registered AddressShop No. 14 Block – Tp, Pitampura, Delhi, India – 110034
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nurad Biotech Private Limited
FY 2025 filings availableNurad Biotech Private Limited reported revenue of ₹15.15 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹2.11 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹1.51 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | 13.9% |
| Net Profit Margin | 10% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nurad Biotech Private Limited, buy the company report.
Board of directors of Nurad Biotech Private Limited
Nurad Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandana Kalra | Director | 25 Jul 2024 | 2 Years 3 Months | Current |
| Rajesh Dua | Director | 23 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Nurad Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gogramin Private Limited | ₹15.26 Lakh (FY 2023) | 38.0% | Rohtak, Haryana, India | |||
| United Remedies India Private Limited | ₹15.25 Lakh (FY 2021) | -14.0% | Lucknow, Uttar Pradesh, India | |||
| Innovist India Private Limited | ₹15.23 Lakh (FY 2018) | -9.0% | Delhi, India | |||
| Eurosun Biopharma Private Limited | ₹15.21 Lakh (FY 2019) | 127.0% | Pune, Maharashtra, India | |||
| Biovitas Lifescience Private Limited | ₹15.18 Lakh (FY 2023) | -7.0% | Surat, Gujarat, India | |||
| Nurad Biotech Private Limitedthis company | ₹15.15 Lakh (FY 2025) | ₹1.51 Lakh | 10% | Delhi, India | ||
| Indmedica Private Limited | ₹15.15 Lakh (FY 2025) | Vadodara, Gujarat, India | ||||
| Synthecis Pharmaceuticals Private Limited | ₹15.07 Lakh (FY 2025) | 854.0% | Hyderabad, Telangana, India | |||
| Awesome Pharmaceuticals Private Limited | ₹15.06 Lakh (FY 2025) | -71.0% | Lucknow, Uttar Pradesh, India | |||
| Kalysta Pharmaceuticals Private Limited | ₹15.06 Lakh (FY 2018) | Mumbai, Maharashtra, India | ||||
| Dr Velankars the Herbal Shopee Private Limited | ₹15.04 Lakh (FY 2025) | 2.0% | Sangali, Maharashtra, India |
To see the full peer comparison of Nurad Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nurad Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nurad Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nurad Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nurad Biotech Private Limited has 3 board changes on record since 2024: 2 appointments and 1 cessation. The latest: Samir Kumar Kalra ceased to be Director on 20 Sep 2024.
Frequently asked questions
Nurad Biotech is an active private limited company based in Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 25 July 2024 (2+ years old) and is registered under CIN U21001DL2024PTC434584.
Nurad Biotech has 2 current directors:
- Vandana Kalra - Director
- Rajesh Dua - Director
The latest financial statements of Nurad Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Nurad Biotech is U21001DL2024PTC434584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nurad Biotech was incorporated on 25 July 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nurad Biotech by revenue are Gogramin Private Limited, United Remedies India Private Limited, Innovist India Private Limited, Eurosun Biopharma Private Limited, Biovitas Lifescience Private Limited and 5 more, all in the Pharma industry (Formulations).
Samir Kumar Kalra ceased to be Director on 20 Sep 2024. Rajesh Dua was appointed as Director on 23 Aug 2024. Vandana Kalra was appointed as Director on 25 Jul 2024.
The registered office of Nurad Biotech is at Shop No. 14 Block – Tp, Pitampura, Delhi, India – 110034.
Nurad Biotech operates in the paper industry, in the paper and paper products segment.
Nurad Biotech can be reached at its registered office: Shop No. 14 Block – Tp, Pitampura, Delhi, India – 110034.
Nurad Biotech is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
